University of Pittsburgh Cancer Institute Investigational Drug Service is a clinical research site located in Pittsburgh, Pennsylvania, United States 15232.
Crixeo Health Trust Score: 41/100 (POOR). This profile has not yet been claimed by the site owner.
University of Pittsburgh Cancer Institute Investigational Drug Service has participated in 1 clinical trials.
Therapeutic areas: Ovarian Cancer.
Sponsors: Pfizer.
Trust Score: 41/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
University of Pittsburgh Cancer Institute Investigational Drug Service has a Crixeo Trust Score of 41/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
University of Pittsburgh Cancer Institute Investigational Drug Service has 1 clinical trials on record. Their work covers Ovarian Cancer.
University of Pittsburgh Cancer Institute Investigational Drug Service has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.